Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Tria
The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods
| Agency | National Institutes of Health |
|---|---|
| Status | Posted |
| Opportunity number | PAR-27-111 |
| Posted date | 06/01/2026 |
| Application deadline | May 07, 2029 12:00:00 AM EDT |
| Award ceiling | none |
| Award floor | none |
| Estimated total funding | 0 |
| Who can apply | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
| Assistance Listing (CFDA) | 93.865 |
| Description | The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission. |
| Agency contact | nichd_fib_nofos@mail.nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/360583 |